Director, Museum of Osteopathic Medicine, USA, E-mail: [email protected]
Pharmaceutical Conference Committee is glad to announce “19th Annual Congress on Pharmaceutics & Drug Delivery Systems” during June 18-19, 2020 in Geneva, Switzerland, after the successful completion of Euro Pharmaceutics 2019 held at Amsterdam, Netherlands during June 27-28, 2019.
Euro Pharmaceutics 2020 conference will mainly focus on the theme: “Accomplishing Innovative Approaches in Pharmaceutical Science”.
Euro Pharmaceutics 2020 developments are maintaining their momentum. 2020 Pharmaceutical Conference program delves into strategic discussions regarding: Pharmaceutical Technology, Drug Targeting and Design, Biopharmaceutics and Biologic Drugs, Anticancer drug delivery for tumor targeting, Novel Drug Delivery Systems, Medical Devices for Drug Delivery, Nanomedicine and Nanotechnology, Pre-formulation & formulation Aspects, Biomaterials in Drug Delivery, Medicinal Chemistry and Drug Discovery, The future of Pharma R&D, Drug Delivery Research, Industrial Pharmacy and Pharmacognosy, Peptides and Protein Drug Delivery, Pharmaceutical Business and Market, Immunotherapy and Vaccines in Drug Deliveryand many more…
Pharmaceuticals in one of the main and essential field for the welfare of human society and it are also one of the largest in the global economy. The total value of the pharmaceutical sector is over $5 trillion. It is one thousand-fold more when compared to what is was in the 1920s. Additionally, the pharmaceutical industry is expected to multiple in size in by 2060 and the pharmaceutical industry is around 30% larger than previously thought and is one of top five in the global economy.
The total market value of drug delivery technology is estimated to reach USD 1,669.40 Billion by 2021 from USD 1,179.20 Billion in 2016, at a CAGR of 7.2% during the forecast period.
3M Company Alkermes Antares Pharma, Inc. Bayer AG Becton, Dickinson And Company F. Hoffmann-La Roche Ltd. Generex Biotechnology Glaxosmithkline Plc Johnson & Johnson Services, Inc. Merck & Co., Inc. Novartis AG Pfizer, Inc. Psivida Corporation Sanofi S.A. Vectura Group Plc.
In recent years, there has been a rising demand for specialty medicines that is expected to ultimately influence the small molecule drug discovery market in a positive manner, as most of the specialty medicines are small molecules. The continuing growth in the healthcare outflow regionally helps the new pharmaceutical technology advancement. Although with high expenditure, there is a need for redirecting the resources, the transition toward better usability of healthcare expenditure for drug development is under progress. The world-wide drug discovery market is segmented by drug type, technology, service, end-user and geography. By geography, the market is segmented by North America, Europe, Asia-Pacific, Middle East and Africa and South America.
In this fame, we look forward for your contribution and astonishing dedication. We accept as true your membership in Euro Pharmaceutics 2020 during June 18-19, 2020 at Geneva, Switzerland will develop the success of the conference.
Program Director | Euro Pharmaceutics 2020
Email: [email protected]